# Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells

> **NCT05187104** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus** · enrollment: 20 (estimated)

## Conditions studied

- Age-Related Macular Degeneration

## Interventions

- **BIOLOGICAL:** Cultured retinal stem and progenitor cells
- **OTHER:** Standard treatment according to the clinical protocols

## Key facts

- **NCT ID:** NCT05187104
- **Lead sponsor:** Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05187104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05187104, "Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT05187104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*